1. 2024
  2. Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis

    Perevalova, A. M., Kononchuk, V. V., Kalinina, T. S., Kozlov, V. V., Gulyaeva, L. F. & Pustylnyak, V. O., Jun 2024, In: Cancers. 16, 12, 2208.

    Research output: Contribution to journalArticlepeer-review

  3. Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers

    Kalinina, T. S., Kononchuk, V. V., Valembakhov, I. S., Pustylnyak, V. O., Kozlov, V. V. & Gulyaeva, L. F., Feb 2024, In: Biomeditsinskaia khimiia. 70, 1, p. 52-60 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. 2023
  5. Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation

    Mazin, M. E., Perevalova, A. M., Yarushkin, A. A., Pustylnyak, Y. A., Rogachev, A. D., Prokopyeva, E. A., Gulyaeva, L. F. & Pustylnyak, V. O., Aug 2023, In: Biochemistry (Moscow). 88, 8, p. 1061-1069 9 p.

    Research output: Contribution to journalArticlepeer-review

  6. Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis

    Pustylnyak, V. O., Alekseenok, E. Y., Perevalova, A. M., Kozlov, V. V. & Gulyaeva, L. F., Aug 2023, In: Heliyon. 9, 8, 10 p., e19044.

    Research output: Contribution to journalArticlepeer-review

  7. 2022
  8. Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium

    Perevalova, A. M., Kobelev, V. S., Sisakyan, V. G., Gulyaeva, L. F. & Pustylnyak, V. O., Nov 2022, In: Biochemistry (Moscow). 87, 11, p. 1310-1326 17 p.

    Research output: Contribution to journalReview articlepeer-review

  9. Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation

    Mazin, M. E., Yarushkin, A. A., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., May 2022, In: Molecular Biology Reports. 49, 5, p. 4089-4093 5 p.

    Research output: Contribution to journalArticlepeer-review

  10. 2021
  11. miRNA expression and interaction with the 3′UTR of FMR1 in FRAXopathy pathogenesis

    Dolskiy, A. A., Yarushkin, A. A., Grishchenko, I. V., Lemskaya, N. A., Pindyurin, A. V., Boldyreva, L. V., Pustylnyak, V. O. & Yudkin, D. V., Mar 2021, In: Non-coding RNA Research. 6, 1, p. 1-7 7 p.

    Research output: Contribution to journalArticlepeer-review

  12. 2020
  13. Noncanonical constitutive androstane receptor signaling in gene regulation

    Pustylnyak, Y. A., Gulyaeva, L. F. & Pustylnyak, V. O., 14 Sept 2020, In: International Journal of Molecular Sciences. 21, 18, p. 1-10 10 p., 6735.

    Research output: Contribution to journalReview articlepeer-review

  14. Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Jul 2020, In: European Journal of Pharmacology. 879, 5 p., 173135.

    Research output: Contribution to journalArticlepeer-review

  15. 2019
  16. Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Sept 2019, In: Archives of Biochemistry and Biophysics. 672, p. 108065 7 p., 108065.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next

ID: 3444310